Answers are grounded in this paper and cite their sources.
Our findings are in keeping with current guidelines that recommend targeting clozapine levels above 350 ng/ml before augmentation is considered. As some clozapine associated ADRs are dose dependent, levels above 600 ng/ml may have an unfavourable risk-benefit ratio.
No takes yet. Share an insight, caveat, or question.
Siskind et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: